The Veterinary Comparative and Clinical Immunology Society (VCCIS) Inc. invites applications for funding of projects investigating clinical or comparative immunology of cats, dogs, food-producing animals or horses for up to a maximum sum of $6,000 and to be completed within 2 years of funding being awarded. Such proposals may include, but are not limited to, investigations of immune-mediated disease, allergy, immunodeficiency, vaccine immunology, immunity to infectious diseases, and immunomodulatory therapies. While novel approaches are welcomed, VCCIS will also be happy to consider proposals to repeat previous studies in a more robust manner to improve the quality of the evidence base. VCCIS encourages a collaborative approach among some combination of clinicians, laboratory scientists, bioinformaticians, and human clinicians and researchers. Eligibility is limited to members of the VCCIS organization (Please contact us if you have questions on whether a trainee or resident would meet this criterion).
Priority will be given to proposed studies that:
The deadline for proposals is 5 pm ET on March 1, 2024.
Applicants will be notified about funding by May 1, 2024 and funding will be provided by July 1, 2024.
The VCCIS grant is made possible by generous support from Boehringer Ingelheim Ltd.